Osaic Holdings
FOLD

Osaic Holdings’s Amicus Therapeutics FOLD Stock Holding History

Osaic Holdings’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$27.4K Sell
1,896
-887
-32% -$12.7K ﹤0.01% 5646
2025
Q4 		$39.6K Sell
2,783
-586
-17% -$5.76K ﹤0.01% 5395
2025
Q3 		$26.4K Sell
3,369
-735
-18% -$5.23K ﹤0.01% 5736
2025
Q2 		$25.1K Buy
4,104
+3,358
+450% +$21.7K ﹤0.01% 5539
2025
Q1 		$6.09K Sell
746
-3,524
-83% -$32.6K ﹤0.01% 6075
2024
Q4 		$40.2K Sell
4,270
-243
-5% -$2.53K ﹤0.01% 4853
2024
Q3 		$48.2K Sell
4,513
-7,929
-64% -$86.4K ﹤0.01% 4775
2024
Q2 		$123K Sell
12,442
-3,912
-24% -$40.2K ﹤0.01% 3970
2024
Q1 		$193K Sell
16,354
-27,477
-63% -$351K ﹤0.01% 3726
2023
Q4 		$622K Buy
43,831
+24,301
+124% +$276K ﹤0.01% 2966
2023
Q3 		$237K Buy
19,530
+4,166
+27% +$53.7K ﹤0.01% 3875
2023
Q2 		$193K Sell
15,364
-201
-1% -$2.38K ﹤0.01% 3916
2023
Q1 		$173K Buy
15,565
+1,120
+8% +$13.8K ﹤0.01% 3985
2022
Q4 		$176K Buy
14,445
+4,448
+44% +$50.1K ﹤0.01% 3963
2022
Q3 		$104K Buy
9,997
+379
+4% +$4.22K ﹤0.01% 4334
2022
Q2 		$103K Buy
9,618
+259
+3% +$2.13K ﹤0.01% 4394
2022
Q1 		$88K Sell
9,359
-157
-2% -$1.47K ﹤0.01% 4681
2021
Q4 		$110K Buy
9,516
+2,217
+30% +$24.7K ﹤0.01% 4511
2021
Q3 		$70K Sell
7,299
-1,552
-18% -$15.9K ﹤0.01% 4835
2021
Q2 		$85K Sell
8,851
-2,861
-24% -$27.9K ﹤0.01% 4621
2021
Q1 		$116K Buy
11,712
+8,624
+279% +$133K ﹤0.01% 4228
2020
Q4 		$71K Buy
3,088
+11
+0.4% +$225 ﹤0.01% 4297
2020
Q3 		$45K Buy
3,077
+1,589
+107% +$23.2K ﹤0.01% 4373
2020
Q2 		$24K Sell
1,488
-344
-19% -$4.19K ﹤0.01% 4686
2020
Q1 		$16K Buy
+1,832
New +$17.4K ﹤0.01% 4752

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Osaic Holdings's FOLD Position: Q1 2026 in Review

Osaic Holdings reduced its Amicus Therapeutics (FOLD) stake by 32% in Q1 2026, selling an estimated $12.7K and leaving 1,896 shares worth $27.4K. The position accounts for ﹤0.01% of the portfolio, ranked #5646.

Osaic Holdings first reported a position in FOLD in Q1 2020 and has held it in 25 quarters since. The position peaked at $622K in Q4 2023. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Osaic Holdings held 1,896 shares of Amicus Therapeutics worth $27.4K as of Q1 2026.
  • Osaic Holdings sold 887 Amicus Therapeutics shares in Q1 2026, an estimated $12.7K.
  • Amicus Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #5646 holding.
  • Osaic Holdings first reported a position in Amicus Therapeutics in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's Amicus Therapeutics position peaked at $622K in Q4 2023.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.